News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,725 Results
Type
Article (14330)
Company Profile (281)
Press Release (255114)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (80121)
Career Advice (155)
Deals (13316)
Drug Delivery (35)
Drug Development (50525)
Employer Resources (31)
FDA (5756)
Job Trends (5161)
News (145230)
Policy (10095)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (920)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21809)
ALS (64)
Alzheimer's disease (848)
Antibody-drug conjugate (ADC) (100)
Approvals (5784)
Artificial intelligence (123)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4577)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (155)
Cancer (1477)
Cardiovascular disease (117)
Career advice (135)
Career pathing (3)
CAR-T (116)
Cell therapy (328)
Cervical cancer (8)
Clinical research (41126)
Collaboration (541)
Compensation (258)
Complete response letters (13)
COVID-19 (1035)
CRISPR (41)
C-suite (163)
Cystic fibrosis (76)
Data (1515)
Denatured (11)
Depression (29)
Diabetes (138)
Diagnostics (1309)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (4)
Duchenne muscular dystrophy (90)
Earnings (30059)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48769)
Executive appointments (460)
FDA (6453)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (97)
Generative AI (10)
Gene therapy (252)
GLP-1 (366)
Government (1089)
Grass and pollen (2)
Guidances (21)
Healthcare (6653)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (91)
Indications (21)
Infectious disease (1100)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (68)
Interviews (17)
IPO (7304)
IRA (11)
Job creations (870)
Job search strategy (128)
Kidney cancer (7)
Labor market (5)
Layoffs (208)
Leadership (3)
Legal (1408)
Liver cancer (33)
Lung cancer (205)
Lymphoma (100)
Machine learning (3)
Management (7)
Manufacturing (138)
MASH (53)
Medical device (2660)
Medtech (2661)
Mergers & acquisitions (6343)
Metabolic disorders (389)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1255)
NextGen: Class of 2025 (2043)
Non-profit (860)
Northern California (1696)
Now hiring (22)
Obesity (194)
Opinion (102)
Ovarian cancer (63)
Pain (43)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (128)
Patient recruitment (76)
Peanut (35)
People (25801)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14528)
Phase II (19136)
Phase III (12086)
Pipeline (804)
Policy (44)
Postmarket research (853)
Preclinical (6140)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (292)
Real estate (1436)
Recruiting (12)
Regulatory (8668)
Reports (15)
Research institute (942)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (59)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1485)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1983)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (8)
The Weekly (36)
United States (13224)
Vaccines (213)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (120)
Last 7 days (526)
Last 30 days (1578)
Last 365 days (19606)
2025 (6203)
2024 (20597)
2023 (22502)
2022 (26930)
2021 (27939)
2020 (23503)
2019 (16325)
2018 (11818)
2017 (13798)
2016 (11887)
2015 (14384)
2014 (10426)
2013 (7531)
2012 (7608)
2011 (7711)
2010 (7507)
Location
Africa (150)
Alabama (42)
Alaska (2)
Arizona (54)
Arkansas (5)
Asia (17446)
Australia (2951)
California (3844)
Canada (1140)
China (359)
Colorado (149)
Connecticut (152)
Delaware (102)
Europe (37329)
Florida (463)
Georgia (115)
Idaho (16)
Illinois (231)
India (10)
Indiana (91)
Iowa (2)
Japan (73)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (473)
Massachusetts (3070)
Michigan (71)
Minnesota (144)
Mississippi (1)
Missouri (31)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (958)
New Mexico (12)
New York (1040)
North Carolina (551)
North Dakota (5)
Northern California (1696)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (739)
Puerto Rico (6)
Rhode Island (19)
South America (209)
South Carolina (5)
Southern California (1485)
Tennessee (25)
Texas (447)
Utah (53)
Virginia (78)
Washington D.C. (30)
Washington State (351)
Wisconsin (15)
269,725 Results for "genesis therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration
February 20, 2025
·
4 min read
Press Releases
Genesis Therapeutics Expands Leadership Team with Appointments of Chief Scientific Officer, SVP of Engineering, and Board Chairman
December 11, 2024
·
4 min read
Press Releases
Alpha Genesis Proposes Innovative Management Model to Transform National Primate Research Centers
March 6, 2025
·
2 min read
Press Releases
Genesis Therapeutics Announces New Equity Investment and Collaboration with NVIDIA to Optimize Key Computational Methods for AI-powered Drug Discovery
November 13, 2024
·
2 min read
Press Releases
Genesis Innovation Group Launches New Website and Branding to Support New Market Growth
November 26, 2024
·
2 min read
Biotech Bay
Genesis Therapeutics Closes Oversubscribed $200 Million Series B
Genesis Therapeutics, a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for patients with severe diseases, announced today that it has closed an oversubscribed $200 million round of Series B financing.
August 21, 2023
·
5 min read
BioMidwest
Celebrating Its Fifth Anniversary, Genesis Reference Laboratories Announces Testing Upgrades
Genesis Reference Laboratories, a leading diagnostics laboratory, is pleased to announce upgrades to its testing menus.
February 8, 2024
·
3 min read
Business
Tim Czartoski Appointed as CEO of Genesis Innovation Group
Genesis Innovation Group is excited to announce the appointment of Tim Czartoski as Chief Executive Officer effective April 1, 2024, and serving in an advisory role until that time.
January 22, 2024
·
3 min read
Press Releases
FELDAN THERAPEUTICS COMPLETES A US$ 21 MILLION SERIES B FINANCING CO-LED BY GENESYS CAPITAL AND FONDS DE SOLIDARITÉ FTQ
September 4, 2024
·
4 min read
Press Releases
Santhera Enters into an Exclusive Distribution Agreement with GENESIS Pharma for AGAMREE® (Vamorolone) in Central and Eastern Europe
September 10, 2024
·
6 min read
1 of 26,973
Next
